Earnings call transcript: DocuSign beats Q2 2026 EPS and revenue forecasts

DocuSign Inc. reported strong Q2 2026 results, surpassing EPS and revenue forecasts with 9% year-over-year revenue growth to $801 million and 13% billings growth to $818 million, driven by its core e-signature business, CLM, and initial traction from its AI-powered Intelligent Agreement Management (IAM) platform. Despite this robust financial performance and an outlook projecting IAM to become a low double-digit percentage of its book by year-end, the stock saw a modest 0.53% aftermarket dip, potentially reflecting profit-taking. The company reiterated its commitment to operational efficiency and capital returns, repurchasing $200 million in shares.

Analysis

DocuSign (DOCU) reported a robust second quarter for fiscal 2026, surpassing consensus estimates with revenue of $800.6 million, up 9% year-over-year, and an EPS of $0.92, an 8.24% beat. The key top-line metric, billings, showed significant strength, growing 13% year-over-year to $818 million, propelled by solid performance in the core e-signature business, a strong quarter for Contract Lifecycle Management (CLM), and early traction from the new AI-powered Intelligent Agreement Management (IAM) platform. This operational strength is further evidenced by the improvement in the dollar net retention rate to 102%, up from 99% a year prior, which management attributes to enhanced gross retention. A central pillar of the company's growth strategy is the IAM platform, which is on track to constitute a low double-digit percentage of the subscription book by year-end and is already showing a "meaningful expansion" in deal size for upgrading customers. Despite these strong results and a $200 million share repurchase, the stock experienced a minor 0.53% decline in aftermarket trading. This muted reaction may be linked to the Q3 billings growth guidance of 5%, which reflects a timing headwind from early renewals that benefited Q2, even though full-year revenue guidance was raised.

Key Decisions for Investors

• Investors should closely monitor the adoption rate and economic uplift from the Intelligent Agreement Management (IAM) platform, as its success is the primary catalyst for the company's targeted re-acceleration to double-digit growth.
• Pay close attention to billings trajectory beyond Q3, as the guided slowdown to 5% YoY growth is attributed to timing; sustained strength in the core e-signature business will be crucial to validate the underlying health and overcome these quarterly fluctuations.
• Given the strong free cash flow margin of 27%, ongoing share buybacks, and a reported P/E of 13.95, the current valuation could be viewed as an attractive entry point for those confident in the long-term IAM growth narrative.
• The improved dollar net retention rate of 102% is a key health indicator, and its stability or continued improvement should be considered a validation of the core business's resilience and the foundation for the IAM upsell strategy.